H Richard Alexander Selected Research

H Richard Alexander Research Topics

Disease

65	Neoplasms (Cancer) 04/2024 - 03/2002
22	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2002
17	Mesothelioma 10/2023 - 12/2003
15	Melanoma (Melanoma, Malignant) 04/2016 - 05/2002
12	Adenocarcinoma 04/2024 - 02/2004
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2008
9	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 03/2002
7	Hyperthermia 07/2010 - 03/2002
5	Peritoneal Neoplasms 01/2020 - 02/2009
5	Insulinoma 04/2009 - 06/2002
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 04/2004
3	Hyperparathyroidism 12/2008 - 12/2002
2	Neoplasms, Cystic, Mucinous, and Serous 02/2024 - 09/2023
2	Pancreatic Fistula (Pancreatic Fistulas) 09/2023 - 01/2022
2	Aggressive Fibromatosis (Desmoid) 09/2022 - 01/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 11/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 02/2004
2	Disease Progression 12/2016 - 09/2006
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 12/2008 - 06/2002
2	Liver Neoplasms (Liver Cancer) 03/2008 - 01/2004
1	COVID-19 04/2024
1	Necrosis 12/2023
1	Granuloma 12/2023
1	Cysts 09/2023
1	Stomach Neoplasms (Stomach Cancer) 11/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022
1	Fibroma (Fibromatosis) 09/2022
1	Infections 01/2022
1	Hepatitis C 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2019
1	Carcinoma (Carcinomatosis) 02/2016
1	Cicatrix (Scar) 01/2016
1	Fibrosis (Cirrhosis) 06/2014

Drug/Important Bio-Agent (IBA)

12	Melphalan (Alkeran)FDA LinkGeneric 04/2016 - 09/2003
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
5	CytokinesIBA 02/2013 - 09/2003
4	Messenger RNA (mRNA)IBA 11/2023 - 02/2006
4	Gemcitabine FDA Link 12/2021 - 09/2008
4	Cisplatin (Platino)FDA LinkGeneric 06/2013 - 12/2003
3	N-acetyltalosaminuronic acid (NAT)IBA 11/2023 - 01/2021
3	Interleukin-8 (Interleukin 8)IBA 01/2020 - 02/2006
3	Fluorouracil (Carac)FDA LinkGeneric 06/2014 - 12/2003
3	CalciumIBA 04/2009 - 12/2003
3	Interleukin-1 (Interleukin 1)IBA 11/2006 - 09/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2006 - 10/2002
2	AntibodiesIBA 12/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2005
2	Verteporfin (Visudyne)FDA Link 09/2023 - 01/2020
2	Capecitabine (Xeloda)FDA Link 12/2021 - 01/2010
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 08/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 11/2006
2	AsbestosIBA 01/2020 - 01/2019
2	matrigelIBA 01/2020 - 10/2018
2	Macrophage Migration-Inhibitory FactorsIBA 01/2016 - 02/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2014 - 02/2005
2	Cadherins (E-Cadherin)IBA 02/2013 - 12/2007
2	Gold Colloid (Colloidal Gold)IBA 12/2010 - 06/2007
2	Carcinoembryonic AntigenIBA 07/2009 - 02/2005
2	Anesthetics (Anesthetic Agents)IBA 02/2009 - 03/2008
2	Tissue Inhibitor of Metalloproteinase-2IBA 12/2007 - 07/2004
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2006 - 09/2003
2	Angiogenic ProteinsIBA 11/2006 - 02/2006
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2006 - 09/2003
2	Thromboplastin (Tissue Factor)IBA 09/2004 - 08/2002
2	Complementary DNA (cDNA)IBA 12/2003 - 07/2002
2	Insulin (Novolin)FDA Link 12/2003 - 09/2002
2	LuciferasesIBA 11/2003 - 10/2002
1	Poly Adenosine Diphosphate RiboseIBA 01/2023
1	KynurenineIBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020
1	TransglutaminasesIBA 10/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 08/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2016
1	Orphan Nuclear ReceptorsIBA 01/2016

Therapy/Procedure

30	Therapeutics 01/2023 - 04/2002
22	Drug Therapy (Chemotherapy) 01/2024 - 03/2002
9	Hyperthermic Intraperitoneal Chemotherapy 10/2023 - 02/2013
8	Cytoreduction Surgical Procedures 09/2022 - 02/2009
5	Neoadjuvant Therapy 04/2024 - 01/2021
3	Pancreatectomy 02/2024 - 06/2002
3	Immunotherapy 01/2022 - 07/2002
3	Aftercare (After-Treatment) 12/2010 - 04/2005
3	Parathyroidectomy 12/2003 - 11/2002
2	Adjuvant Chemotherapy 01/2024 - 09/2022
2	Metastasectomy 11/2022 - 01/2003
2	Pancreaticoduodenectomy 10/2022 - 01/2021
2	Chemoradiotherapy 12/2021 - 01/2010
2	Laparotomy 05/2012 - 12/2003
2	Injections 01/2010 - 09/2004
2	Catheters 03/2008 - 05/2005
2	Hemofiltration 03/2008 - 05/2005
1	Colectomy 04/2024
1	Appendectomy 04/2024
1	Gastrectomy 11/2022
1	Length of Stay 01/2022
1	Liver Transplantation 01/2020
1	Cesarean Section (Caesarean Section) 01/2016